Analysts nailed it: Skubal's 2025 dominance fulfills MLB.com predictions

Building on trade rumors from the MLB Winter Meetings, Detroit Tigers ace Tarik Skubal validated pre-season forecasts by MLB.com analysts in 2025, leading the AL in ERA (2.21) and winning his second straight Cy Young Award. With 2026 as his final year under team control, the Tigers must weigh extension, trade, or contention plans.

Tarik Skubal's 2025 season exceeded expectations, confirming MLB.com analysts' bold pre-campaign prediction that he would lead the American League in ERA and capture the Cy Young Award. His 2.21 ERA improved on 2024's league-leading 2.39, marking the first back-to-back AL ERA titles since Pedro Martinez in 2002-03—the same pitcher now drawing comparisons to Skubal's rare streak of consecutive Cy Youngs.

This elite performance, detailed amid earlier Winter Meetings trade buzz, intensifies focus on Skubal's future. Entering 2026 with one year of control left, the Tigers face pivotal choices: pursue a massive extension, trade for prospects, or ride him toward a World Series push. Fan interest has surged with Detroit's back-to-back promising campaigns, but roster gaps remain.

As speculation persists—linking teams like the Dodgers and Mets—Skubal's trajectory hints at another dominant year if he stays, contingent on front-office moves this offseason.

Связанные статьи

Detroit Tigers pitcher Tarik Skubal said the team must play better baseball or risk front office reassessment at the trade deadline. The club has posted an 11-6 record this month while sitting at 33-44 overall.

Сообщено ИИ

Detroit Tigers left-hander Tarik Skubal will undergo surgery to remove loose bodies from his elbow after the team announced the procedure on Monday. The two-time Cy Young winner is expected to miss two to three months, raising questions about his performance and contract value heading into free agency after the 2026 season.

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить